BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22117833)

  • 41. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 'Bronchioloalveolar carcinoma': is the term really dead? A critical review of a new classification system for pulmonary adenocarcinomas.
    Xu L; Tavora F; Burke A
    Pathology; 2012 Oct; 44(6):497-505. PubMed ID: 22990278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons.
    Lee HY; Lee KS; Han J; Kim BT; Cho YS; Shim YM; Kim J
    Lung Cancer; 2009 Aug; 65(2):170-5. PubMed ID: 19111932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
    Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
    Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathological features of lung adenocarcinoma with KRAS mutations.
    Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I
    Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma.
    Borczuk AC
    Mod Pathol; 2012 Jan; 25 Suppl 1():S1-10. PubMed ID: 22214965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiating bronchioloalveolar carcinoma from adenocarcinoma.
    Schraufnagel D; Peloquin A; Paré JA; Wang NS
    Am Rev Respir Dis; 1982 Jan; 125(1):74-9. PubMed ID: 6278997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.
    Haneda H; Sasaki H; Lindeman N; Kawano O; Endo K; Suzuki E; Shimizu S; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Feb; 36(2):69-75. PubMed ID: 16449241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
    Al-Zahrani IH
    Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
    Xu L; Tavora F; Battafarano R; Burke A
    Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma.
    Ito A; Okada M; Uchino K; Wakayama T; Koma Y; Iseki S; Tsubota N; Okita Y; Kitamura Y
    Lab Invest; 2003 Aug; 83(8):1175-83. PubMed ID: 12920246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The new classification of lung adenocarcinoma].
    Petersen I
    Zentralbl Chir; 2013 Oct; 138 Suppl 1():S16-24. PubMed ID: 24150851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
    Wu J; Chu PG; Jiang Z; Lau SK
    Am J Clin Pathol; 2013 Feb; 139(2):160-6. PubMed ID: 23355200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimally invasive adenocarcinomas of the lung.
    Dacic S
    Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
    Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
    J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact.
    Sterlacci W; Savic S; Schmid T; Oberaigner W; Auberger J; Fiegl M; Tzankov A
    Am J Clin Pathol; 2012 Jun; 137(6):946-56. PubMed ID: 22586054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
    Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger KR; Yatabe Y; Beer DG; Powell CA; Riely GJ; Van Schil PE; Garg K; Austin JH; Asamura H; Rusch VW; Hirsch FR; Scagliotti G; Mitsudomi T; Huber RM; Ishikawa Y; Jett J; Sanchez-Cespedes M; Sculier JP; Takahashi T; Tsuboi M; Vansteenkiste J; Wistuba I; Yang PC; Aberle D; Brambilla C; Flieder D; Franklin W; Gazdar A; Gould M; Hasleton P; Henderson D; Johnson B; Johnson D; Kerr K; Kuriyama K; Lee JS; Miller VA; Petersen I; Roggli V; Rosell R; Saijo N; Thunnissen E; Tsao M; Yankelewitz D
    J Thorac Oncol; 2011 Feb; 6(2):244-85. PubMed ID: 21252716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of Galectin-3, CD138, p16INK4a, and TTF-1 in mucinous bronchioloalveolar adenocarcinoma after Hodgkin lymphoma.
    Al-Salam S; Al-Ashari M
    Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):351-6. PubMed ID: 18997617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
    Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
    Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.